Successful thrombolysis of right atrial and ventricle thrombi encircling a temporary pacemaker lead in a patient with heparin-induced thrombocytopenia type II

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 4 I, 1999, Pages 678-681

  Janssens, Uwe ^a   Breithardt, O A ^b   Greinacher, A ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b NONE

Author keywords

Artificial pacemaker; Heparin adverse effects; Hirudin therapeutic use; Thrombocytopenia; Thrombosis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; DANAPAROID; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD CLOT LYSIS; CASE REPORT; DRUG INDUCED DISEASE; HEART VENTRICLE THROMBOSIS; HUMAN; INTRACARDIAC THROMBOSIS; MALE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; DRUG COMBINATIONS; FIBRINOLYTIC AGENTS; HEART ATRIA; HEART DISEASES; HEART VENTRICLES; HEPARIN; HEPARINOIDS; HEPARITIN SULFATE; HIRUDIN THERAPY; HIRUDINS; HUMANS; PACEMAKER, ARTIFICIAL; THROMBOCYTOPENIA; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032955572     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00514.x     Document Type: Article

References (12)

1. Greinacher A, Michels I, Kiefel V, et al. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991; 66:734-736.
2. Phibbs B, Marriott HJ. Complications of permanent transvenous pacing. N Engl J Med 1985; 312:1428-1432.
3. Pandian NG, Kosowsky BD, Gurewich V. Transfemoral temporary pacing and deep vein thrombosis. Am Heart J 1980; 100:847-851.
4. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332:1330-1335.
5. Greinacher A, Potzsch B, Amiral J, et al. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71:247-251.
6. Magnani HN. Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 1993; 70:554-561.
7. Greinacher A, Amiral J, Dummel V, et al. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34:381-385.
8. Greinacher A, Völpel H, Pötzsch B. Recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT). (abstract) Blood 1996; 88:281a
9. Palatianos GM, Dewanjee MK, Panoutsopoulos G, et al. Comparative thrombogenicity of pacemaker leads. PACE 1994;17:141-145.
10. Mugge A, Gulba DC, Jost S, et al. Dissolution of a right atrial thrombus attached to pacemaker electrodes: Usefulness of recombinant tissue-type plasminogen activator. Am Heart J 1990; 119:1437-1439.
11. Dieck JA, Rizo Patron C, Unisa A, et al. A new manifestation and treatment alternative for heparin-induced thrombosis. Chest 1990; 98:1524-1526.
12. Kronik G. The European cooperative study group on the clinical significance of right heart thrombi. Eur Heart J 1989; 10:1046-1059.